biosimilars - the next big thing | kiran mazumdar shaw to et now
Published 4 years ago • 1.8K plays • Length 8:50Download video MP4
Download video MP3
Similar videos
-
11:29
indian pharma industry is ensuring that global healthcare costs are contained: kiran mazumdar shaw
-
7:42
drug pricing controls detrimental: kiran mazumdar-shaw
-
1:01
on pharma r&d, was hoping for a special call out - kiran mazumdar shaw
-
6:21
pharma an unsung hero needs to be supported by govt initiatives: kiran mazumdar shaw
-
1:58
kiran mazumdar shaw of biocon against drug price control
-
38:56
leadership & philanthropy: kiran mazumdar-shaw in conversation with azim premji
-
11:30
biocon’s billion dollar bet | kiran mazumdar shaw of biocon to et now
-
26:51
biotech is all about precision medicine: kiran mazumdar-shaw | serious business
-
15:46
kiran mazumdar-shaw exclusive: free coronavirus tests unviable for private labs
-
1:11:34
the india series: in conversation with kiran mazumdar-shaw
-
9:08
government, insurance companies should pay for coronavirus tests: kiran mazumdar-shaw
-
1:35
kiran mazumdar-shaw | philanthropy has to be sustainable
-
12:53
kiran mazumdar shaw talks about how technology can solve biggest healthcare problems || ntlf 2019
-
30:03
kiran mazumdar shaw on building a billion-dollar publicly-listed pharma company
-
4:24
why—and how—pharmaceutical companies should transform their commercial operations
-
1:48
kiran mazumdar-shaw | advice to new philanthropists: where can you make a difference?
-
47:34
safety, efficacy of data must for covid vaccine: kiran mazumdar shaw
-
10:17
kiran mazumdar shaw: should do mix & match studies of vaccine to speed up vaccination | cnbc-tv18
-
4:06
kiran mazumdar shaw of biocon on malaysia usfda radar
-
9:02
kiran mazumdar shaw, chairman and managing director, biocon
-
1:16
in business - awaiting regulatory approvals for insulin trials: kiran mazumdar shaw
-
8:31
in insulin bio-similars, our only competitors are original manufacturers: kiran mazumdar shaw,biocon